CELLINK joins collaboration to improve treatment for burn patients
Working with Umeå University and GE Healthcare, CELLINK will help develop a transplantable skin construct to give burn patients a better quality of life. Traditionally, patients with severe burns have received keratinocyte-based epidermal sheet transplants. However, these transplants cannot replace sweat glands, nerves or vasculature, leaving patients far from cured. Patients need to moisturize twice daily and stay inside when it’s too warm, and they experience additional pain and itching with no treatment option but to reduce overall activity. CELLINK is combining expertise with Umeå